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Bites and stings
The current study was begun in September
1989 to evaluate snakebite in the tropical
“Top End” of the Northern Territory. Its aim
was to describe the local epidemiology and
the enveno ing syndromes from the various
venomous snakes present in the region. The
Top End has a climate divided into the hot
and M
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Objective:  To describe the epidemiology of snakebite in the “Top End” of the Northern 
Territory, and the envenoming syndromes of individual snake species.
Study design:  Prospective collection of clinical data and snake identity.
Setting:  Royal Darwin Hospital (RDH), a 300-bed tertiary hospital servicing a population 
of 140 000 spread over 522 561 km2.
Patients:  All patients with bites by confirmed snake species between September 1989 
arch 2003, and all suspected snakebite cases between September 1989 and 
h 1998.
ome measures:  Incidence rates of definite snakebite and envenoming. Clinical 
res of bites from defined snake species.
lts:  There were 348 suspected snakebites over 8.6 years, with 114 aerial 
uations to RDH, 216 patients (62%) definitely bitten (23.2/100 000 per year) and 79 
) envenomed (7.6/100 000 per year). There were 156 bites from confirmed species 
over 13.6 years: 31 (20%) from western brown snakes (Pseudonaja nuchalis), with early 
collapse in 14 (45%), consumptive coagulopathy in 26 (84%) and 25 (81%) given 
antivenom; 21 from death adders (Acanthophis spp.), with neurotoxicity in 8 (38%) 
and 6 (29%) given antivenom; and 20 from mulga snakes (Pseudechis australis), with local 
swelling in 19 (95%), myotoxicity in 12 (60%) and 15 (75%) given antivenom. In 34 bites 
from less venomous species, there was no life-threatening envenoming. There were 
no deaths.
Conclusions:  Snakebite still causes morbidity in tropical Australia, but, with access to 
hospital and antivenom, deaths are rare. This study has enabled further definition of the 
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envenoming syndromes of three highly venomous Australasian elapids.na
of 
deS kebite remains an important causemorbidity in tropical Australia,spite the declining national snake-
bite rates.1 Prospective studies are required
in Australia to better define epidemiological
and clinical features of snakebite from the
many Australasian elapid (front-fanged ven-
omous land snake) species.
monsoonal rainy season from November to
May and the cooler mid-year dry season, but
snakes remain active year-round.
METHODS
Setting
Royal Darwin Hospital (RDH) is a 300-bed
referral hospital servicing the Top End popu-
lation of around 140 000 in an area of
522561 km2. The Top End policy is that all
patients with suspected snakebite are admit-
ted to hospital. Two small district hospitals in
the towns of Katherine and Nhulunbuy care
for snakebite patients in their regions who do
not require transfer to RDH. Aboriginal peo-
ple account for 24% of the population, and
many live in remote isolated communities.
Case details
From September 1989, a standard data col-
lection form has been used for patients
presenting to RDH with suspected snake-
bite. Variables listed include demographic
details, nature of the suspected bite, first aid
treatment, and clinical parameters reflecting
the envenoming syndromes of Australian
snakes. Envenomed patients are managed
by RDH emergency department and inpa-
tient staff in consultation with the author,
according to local protocols.2,3 Data relating
to antivenom use, clinical features and
response to antivenom were also recorded
prospectively.
Each case is only recorded as a definite
snakebite if there is a clear description of a
bite from a snake that was seen, or if there is
clinical evidence of snakebite envenoming.
Otherwise, the case is recorded as “uncer-
tain”. For bitten patients, envenoming is
categorised according to presence of regional
lymphadenitis (differential tenderness on
palpation), non-specific systemic features
(nausea, vomiting, abdominal pain and
headache), coagulopathy (confirmed by pro-
longed prothrombin time and/or partial
thromboplastin time), neurotoxicity (defined
as at least a finding of definite ptosis) and
myotoxicity (confirmed by blood creatine
kinase [CK] concentration higher than
500 U/L; normal range, < 220 U/L).
Systemic envenoming is defined as definite
snakebite and at least one of coagulopathy,
neurotoxicity, myotoxicity, or non-specific
systemic features of envenoming.
Snake identification
Positive identification of the snake is only
recorded where the snake that definitely bit
the patient is brought in (dead or alive) for
identification, either by the author using
standard identification keys4,5 or by a quali-
fied expert (see Acknowledgements), or if
there is a positive Venom Detection Kit
(VDK; CSL Ltd, Parkville, VIC) result in a
patient whose clinical features are consistent
with the test result. Because in the Top End
the only species of the brown snake (Pseu-
donaja) and black snake (Pseudechis) genera
are the western brown (Pseudonaja nuchalis)
and mulga (Pseudechis australis) snakes,6
positive results of the genus-specific VDK
are assumed to be these species. Although
death adders in the Top End had previously
all been considered the northern death
adder species (Acanthophis praelongus), there
are ongoing revisions of the genus Acantho-• Volume 181 Number 11/12 • 6/20 December 2004 693
BITES AND STINGSphis, so these are identified only as Acantho-
phis spp. in this study.5
Statistical analyses and incidence data
All patients presenting to RDH with sus-
pected snakebite from 1 September 1989 to
31 March 1998 were included in an epide-
miological assessment of all suspected
snakebites. Subsequently, from 31 March
1998 until 31 March 2003, data have only
been routinely collected for confirmed
snakebites from positively identified snakes.
For the epidemiological study, data were
stored in an Epi-Info database and descrip-
tive statistics, risk ratios, incidence rates and
incidence rate ratios and their 95% confi-
dence intervals were calculated using Epi-
Info.7 Population figures used were from
Territory Health Services distribution and
projection estimates from the Australian
Bureau of Statistics 1991 Census data, with
averages of the 1993 and 1994 figures (epi-
demiological study mid-point) used as
denominators for incidence rates. Denomi-
nators for incidence rates were based on the
population using RDH as the primary refer-
ral centre; patients transferred to RDH from
the two Top End regional hospitals were
excluded from calculations of incidence
rates. For incidence rates, the total case
numbers were divided by 8.58, reflecting
the 8 years and 7 months of the epidemio-
logical study.
Associations between categorical variables
were analysed using the χ2 test with Yates’
correction or Fisher’s exact test, as appropri-
ate. Comparisons using ages of patients and
time of day of bite were made using the two-
sample t test and Wilcoxon two-sample test,
respectively. P < 0.05 was considered signifi-
cant.
Ethics approval
The study was approved by the Health
Research Ethics Committee of the Royal
Darwin Hospital and the Menzies School of
Health Research.
RESULTS
Epidemiological study of all suspected 
snakebites: 1989–1998 (8.6 years)
There were 348 suspected snakebites, with
216 patients (62%) definitely bitten (see
Box 1). Of those definitely bitten, ages
1 Features of 216 patients with 
definite snakebite: 1989–1998
* No signs or symptoms beyond bite site.
Definite snakebite 
216
Snake identified 
90 (42%)
Envenomed 
79 (37%)
Antivenom given 
40 (19%)
Not envenomed* 
137 (63%)
Regional 
lymphadenitis only 
14 (6%)
Systemically 
envenomed 
65 (30%)
2 Clinical features in 65 systemically 
envenomed patients: 1989–1998
Bite-site swelling 50 (77%)
Regional lymphadenitis 50 (77%)
Early collapse (30 minutes) 
with loss of consciousness
10 (15%)
Non-specific systemic features
Nausea 47 (72%)
Abdominal pain 34 (52%)
Headache 32 (49%)
Vomiting 31 (48%)
Coagulopathy 27 (42%)
Neurotoxicity 13 (20%)
Myotoxicity 11 (17%)
3 Incidence rates and incidence rate ratios for definite bites and envenoming: 1989–1998
Population 
estimate*
Definite 
bites†
Annual bites 
per 100 000 RR (95% CI)
Number 
envenomed‡
Annual envenoming 
per 100 000 RR (95% CI)
Overall 100 845 201 23.2 66 7.6
Sex
Male 52 245 135 30.1 1.9 (1.4–2.6) 46 10.3 2.1 (1.3–3.6)
Female 48 600 66 15.8 1.0 20 4.8 1.0
Age
< 15 years 26 162 41 18.3 0.7 (0.5–1.0) 9 4.0 0.5 (0.2–0.9)
 15 years 74 683 160 25.0 1.0 57 8.9 1.0
Children < 15 years
Male 13 329 22 19.2 1.1 (0.6–2.1) 2 1.8 0.3 (0.1–1.3)
Female 12 833 19 17.3 1.0 7 6.4 1.0
Location
Aboriginal
community‡
8 917 47 61.4 3.2 (2.3–4.4) 18 23.5 3.9 (2.3–6.6)
Other§ 91 928 154 19.5 1.0 48 6.1 1.0
Aboriginal community‡
Male  15 years 2 837 22 90.4 1.7 (0.9–3.4) 11 45.2 3.4 (1.0–12.2)
Female  15 years 2 638 12 53.0 1.0 3 13.3 1.0
* 1993–1994 average for Royal Darwin Hospital (RDH) primary catchment, excluding Gove and Katherine hospital catchments. † Excludes patients transferred to RDH 
from Gove, Katherine or Kimberley, WA. ‡ Aboriginal people living in remote communities. § All other people, predominantly Darwin urban and surrounding semi-rural 
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SD, 16 years), 150 (69%) were male and
61 (28%) were Aboriginal. Box 2 shows
the clinical features in the 65 systemically
envenomed patients. Box 3 shows the
incidence rates for definite snakebite and
for envenoming.
Air evacuation from rural NT areas to
RDH was required for 112 patients, three by
helicopter and the rest by the NT Aerial
Medical Services, at an average cost of about
$3000 per patient. Two other patients were
evacuated to RDH by plane from the adja-
cent Kimberley region of Western Australia.
Seventy-eight children under 15 years of
age had suspected bites, and 47 were defi-
nitely bitten (22% of both groups). Fifteen
children were clinically envenomed (12
with systemic features and three with only
lymphadenitis). In two children, the diagno-
sis of snake envenoming was delayed
because no history of snakebite was forth-
coming on initial presentation.
Snakebite occurred throughout the year,
with the highest incidence during March to
May, accounting for 36% of definite bites,
whereas only 9% occurred in June–July. The
median time of definite bites was 1530, and
78 patients (36%) were bitten at night (1900
to 0600).
Of those definitely bitten, 127 (59%)
were bitten on the foot or ankle, 53 (25%)
on the hand or wrist, 21 (10%) on the lower
leg, 2 (1%) on the forearm and 13 (6%)
elsewhere or uncertain as to where. Of those
bitten on the hand, 16 (30%) were intoxi-
cated by alcohol at the time of bite, com-
pared with 12 (7%) of those bitten
elsewhere (χ2 = 16.5; P < 0.0001). In com-
parison with non-Aboriginal people, Aborig-
inal people were one-third as likely to be
bitten on the hand as elsewhere (RR, 0.32;
95% CI, 0.15–0.72). This is likely to reflect
a greater understanding in Aboriginal peo-
ple of the dangers of handling snakes, as
well as their common lack of protective
footwear.
Confirmed bites from identified 
snakes: 1989–2003 (13.6 years)
Box 4 summarises the 156 snakebites for
which the snake species was confirmed,
and Box 5 shows the clinical features of the
74 bites from snakes in the four potentially
lethal genera present in the Top End,
highlighting the distinct envenoming syn-
dromes from these snakes. There were no
deaths over the 13.6 years.
4 Confirmed snake identification: 1989–2003
Common name Scientific name
Snake 
brought
VDK* 
positive Total
Elapids (venomous)
Highly venomous
Western brown snake Pseudonaja nuchalis 12 19 31
Mulga snake Pseudechis australis 8 12 20
Death adder Acanthophis spp. 13 8 21
Taipan† Oxyuranus scutellatus 1 1
Inland taipan† Oxyuranus 
microlepidotus
1 1
Blue-bellied black snake† Pseudechis guttatus 1 1
Less venomous
Black whip snakes Demansia spp.‡ 17 17
Marble-headed whip snake Demansia olivacea 5 5
Secretive snake Rhinoplocephalus 
pallidiceps
4 4 
Moon snake Furina ornata 3 3
Venomous colubrids (rear-fanged)
Brown tree snake Boiga irregularis 3 3
White-bellied mangrove snake Fordonia leucobalia 1 1
Water snake Enhydris polylepis 1 1
Non-venomous
Slatey grey snake Stegonotus cucullatus 10 10
Children’s python Liasis childreni 12 12
Water python Liasis fuscus 9 9
Carpet python Morelia spilota variegata 8 8 
Olive python Liasis olivacea 4 4
Common (golden) tree snake Dendrelaphis punctulatus 2 2
Keelback Tropidonophis mairii 2 2
* Venom Detection Kit test on urine or bite swab (performed if patient envenomed and no snake brought for 
identification). † Bites from captive snakes in private collection. ‡ Demansia atra or Demansia papuensis.
5 Clinical features of the four highly venomous Top End elapids: 1989–2003 
Western brown 
(n= 31)
Mulga 
(n= 20)
Death adder 
(n= 21)
Taipan 
(n= 2)
Bite-site swelling 9 (29%) 19 (95%) 13 (62%) 2
Regional lymphadenitis 19 (61%) 16 (80%) 13 (62%) 1
Systemic envenoming 26 (84%) 19 (95%) 17 (81%) 2
Early collapse (within 30 min) 14 (45%) 0  0 0
Non-specific systemic features* 23 (74%) 19 (95%) 15 (71%) 2
Coagulopathy 26 (84%) 9 (45%) 0 2
Neurotoxicity 4 (13%) 3 (15%) 8 (38%) 1
Myotoxicity 3 (10%) 12 (60%) 1 (5%) 1 
Prior intoxication 9 (29%) 7 (35%) 2 (10%) 1
Antivenom given 25 (81%) 15 (75%) 6 (29%) 2
* One or more of abdominal pain, nausea, vomiting or headache.MJA • Volume 181 Number 11/12 • 6/20 December 2004 695
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This prospective study is the largest single
series of suspected and confirmed snakebite
reported from an Australian hospital. Snake-
bite incidence rates in Australia have previ-
ously been published from southeast
Queensland, with incidences of snakebite in
children of 7.1 per 100 000 children annu-
ally in 1971–19758 and 2.0–3.5 per 100000
in 1978–1987,9 compared with 18.3 per
100 000 in children in this study from
1989–1998. Australasian elapid snakes are
also present on the island of New Guinea,
where the highest reported incidence rate of
snakebite was 526 per 100 000 in the
Papuan coastal Kairuku subprovince, north
of Port Moresby.10 This is considerably
higher than the rate of 61.4 per 100 000 for
remote Top End Aboriginal communities in
this study, and approaches the highest rates
documented in the world.11,12
In this study, the envenoming rate was
highest among Top End rural Aboriginal
adult males (45.2 per 100 000), compared
with 81.8 per 100 000 in rural central
Papua.13 The incidence of envenoming in
Top End children was 4.0 per 100 000,
compared with 0.2 per 100 000 in a
Queensland study from a decade earlier9
and 17.6 per 100 000 in children from the
Port Moresby region.13
In addition to the Queensland snakebite
studies,8,9 there have been retrospective
series of adults14,15 and children16 from
Western Australia, adults and children from
South Australia17,18 and children from Vic-
toria,19 and a prospective study of 11 cases
from Sydney.20 Jelinek et al described 193
patients with suspected snakebite admitted
to the three Perth adult teaching hospitals
over a 10-year period from 1979.15 Of these,
53 were envenomed, including 13 of the 76
patients admitted to one Perth hospital.14
White described a series of 244 suspected
snakebites in South Australia over a 20-year
period from 1970, with 75 having evidence
of systemic envenoming.18 The Top End
study reported here, and a recent series from
north Queensland,21 confirm earlier data
showing a higher incidence of snakebite in
tropical Australia than in temperate regions
of Australia.22
As with all Australian studies, there was a
male predominance among snakebite vic-
tims in the Top End, with males twice as
likely as females to be bitten or envenomed.
This is consistent with greater occupational
and recreational exposure. However, the
male predominance seen in children in the
Queensland7,9 and Western Australian16
studies was not evident in the Top End.
In temperate Australia, snakebite is com-
monest in January and very unusual in
winter, reflecting snake activity and hiberna-
tion.15 Snakes in tropical Australia are active
all year and envenoming can occur in any
month,2,13 although it is less common in the
cooler months of June to August. March to
May were the commonest months for bites
in this study. This probably relates to
increased human exposure from outdoor
activity at the end of the monsoon as well as
to snake behaviour.
In this study, 36% of those definitely bitten
and 32% of those envenomed (25/79) were
bitten at night (1900 to 0600 hours). This is
higher than in the Papua New Guinea study
of envenomed patients (15% at night)13 and
the studies from Queensland (all bites, 13%
and 9% at night)8,9 and Perth (all bites, 12.5%
at night),15 all of which defined night as 1800
to 0600. The higher Top End night-time
proportion of bites probably reflects rela-
tively greater outdoor nocturnal behaviour of
people, as well as continuing snake activity in
the evenings, which, for example, is recog-
nised for death adders, western brown and
mulga snakes.4-6,23
The predominance of bites on the lower
limbs is consistent with other studies,
although the proportion on the ankle or foot
(59%) was higher than in Queensland (42%
and 41%)8,9 and Western Australian
(49%)15 studies, but less than in Papua New
Guinea.13 This relates to absence of sturdy
footwear in many circumstances in the Top
End and in Papua New Guinea. The associa-
tion between intoxication and bites on the
hands is not surprising and has been noted
before.18
There were three documented cases in
which the snakebite was clearly not a defen-
sive response. Overambitious feeding
attempts by the snakes (mulga snake, slatey
grey snake, and olive python) may account
for this. In each case, the victim woke at
night to find a large snake chewing on an
exposed extremity (two toes and one wrist)
(Box 6).
Many descriptions of Australian enven-
oming syndromes are from cumulative case
reports, although series of bites from various
species have been very informative.14-17,24-27
In this study, strict definitions for envenom-
ing parameters and for confirming snake
identity allowed envenoming syndromes to
be summarised for the three most common
highly venomous Top End elapids (Box 5).
Among bites from 29 less venomous elapids
and five rear-fanged venomous colubrids
(Box 4), there was no life-threatening enven-
oming, with only occasional, non-specific
systemic features in bites from whip snakes
(Demansia spp.) (data not shown).
Bite-site swelling, lymphadenitis and non-
specific systemic features are most promi-
nent in mulga snake envenoming and,
importantly, may occasionally be absent in
brown snake bite with severe consumptive
coagulopathy and fibrinogen depletion (Box
7) and in death adder bite with neurotoxic-
6 Predatory bite on the wrist of a 
sleeping 7-year-old
This semicircular row of teeth marks is from a large 
olive python.
8 Myoglobinuria from myotoxicity 
after mulga snake bite
7 Severe coagulopathy with 
fibrinogen depletion in a 
2-year-old
None of the classical non-specific systemic 
features of snake envenoming (nausea, vomiting, 
headache, abdominal pain) were present. 
Bite was by a western brown snake.696 MJA • Volume 181 Number 11/12 • 6/20 December 2004
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snake envenoming, with severe cases having
marked limb swelling, CK levels over
10 000 U/L and frank myoglobinuria (Box
8). Myotoxicity has generally not been con-
sidered important in death adder and brown
snake envenoming, but elevated CK levels
were occasionally seen in this study with
bites from these snakes. A myotoxin has
been recently described from one death
adder species.28
The dramatic early collapse (within 30
minutes) with recovery, which was seen in
more than half those with systemic enven-
oming from western brown snake bites, has
been attributed to transient myocardial dys-
function and hypotension associated with
microvascular thrombi during the early
phase of the consumptive coagulopathy.2,29
Early collapse is also seen in taipan and tiger
snake envenoming with coagulopathy,2 but
neither early collapse nor coagulopathy was
seen in any mulga snake or death adder
envenomings in this study.
Neurotoxicity is the most important fea-
ture of death adder envenoming, but
occurred in fewer than half the patients in
this series. This may reflect selection bias
towards more severe cases in previous series
from Papua New Guinea,24,25 or the death
adder species in the Top End may be less
venomous. Although both mulga and brown
snake venoms have neurotoxins,4-6,23 neuro-
toxicity was very uncommon in bites from
these species. The rarity of neurotoxicity in
envenoming from brown snakes despite the
presence of potent presynaptic neurotoxins
has been called the “brown snake paradox”.2
This prospective study has defined the
epidemiological features of snakebite in the
Top End and described the envenoming
syndromes from the major venomous
snakes in the region. Prospective studies are
needed elsewhere in Australia to better
define the epidemiology of snakebite and
the clinical features of envenoming from the
diverse species of elapids.
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